Gene: FAM227B
Official Full Name: family with sequence similarity 227 member Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21429 | FAM227B Knockout cell line (HeLa) | Human | FAM227B | 1:3~1:6 | Negative | Online Inquiry |
KO21430 | FAM227B Knockout cell line (HCT 116) | Human | FAM227B | 1:2~1:4 | Negative | Online Inquiry |
KO21431 | FAM227B Knockout cell line (HEK293) | Human | FAM227B | 1:3~1:6 | Negative | Online Inquiry |
KO21432 | FAM227B Knockout cell line (A549) | Human | FAM227B | 1:3~1:4 | Negative | Online Inquiry |
FAM227B Gene Knockout Cell Lines are a cutting-edge research tool designed to study the function and role of the FAM227B gene in various biological contexts. Created through advanced CRISPR-Cas9 gene editing technology, these cell lines enable researchers to investigate the cellular mechanisms influenced by FAM227B deletion, thereby providing insights into its involvement in disease processes and potential therapeutic targets.
The primary function of FAM227B Gene Knockout Cell Lines is to facilitate the investigation of gene function by providing a controlled environment where the FAM227B gene is completely inactivated. This knockout model allows for the exploration of phenotypic changes that may arise due to the absence of FAM227B, including alterations in cell proliferation, differentiation, and response to external stimuli. Researchers can use these cell lines to elucidate FAM227B's role in cancer biology, neurological disorders, and other pathophysiological conditions.
The scientific importance of FAM227B Gene Knockout Cell Lines extends into both fundamental and applied research. In clinical settings, understanding the ramifications of knocking out FAM227B can inform the development of novel therapies, particularly in personalized medicine approaches where specific gene mutations may dictate treatment responses. In research, these cell lines are invaluable for drug discovery, allowing for high-throughput screening of compounds that may reverse or mitigate the effects of FAM227B loss.
Compared to traditional research models, such as transgenic animals or non-specific knockdown approaches, FAM227B Gene Knockout Cell Lines offer several distinct advantages. They are easier and more cost-effective to maintain and manipulate, provide consistent and reproducible results, and allow for scalable experimental designs. Researchers benefit from the clarity and precision of gene knockout methodologies, which offer more reliable data concerning gene function than conventional methods.
The unique capabilities of FAM227B Gene Knockout Cell Lines make them an essential asset for researchers and clinicians who aim to decode the genetic underpinnings of diseases and advance therapeutic interventions. With a commitment to innovation and scientific excellence, our company specializes in providing high-quality biological tools, realizing the potential to accelerate your research and clinical discoveries with our expertly crafted gene knockout models.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.